Posaconazole

December 12, 2011
Image of Posaconazole 3D Image of Posaconazole

Posaconazole is an antifungal drug that was developed by Schering-Plough in the mid-2000s and is marketed under the trade names Noxafil and Posanol. It may be more effective than the older drug fluconazole, but it may also have more serious side effects, such as prolonged heart QT interval. Posaconazole is in Phase II clinical trials for treating Chagas disease, but its ultimate cost may be too high for sufferers of this disease.

Chemical Abstract Service - a division of ACS

Learn more about this molecule from CAS, the most authoritative and comprehensive source for chemical information.

Molecule of the Week needs your suggestions!

If your favorite molecule is not in our archive, please send an email to motw@acs.org. The molecule can be notable for its current or historical importance or for any quirky reason. Thank you!

Stay Ahead of the Chemistry Curve

Learn how ACS can help you stay ahead in the world of chemistry.